Julia G. Butchko's Insider Trades & SAST Disclosures
Julia G. Butchko's most recent trade in Immunovant Inc was a trade of 2,907 Common Stock done at an average price of $31.8 . Disclosure was reported to the exchange on Aug. 21, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Julia G. Butchko.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 31.84 per share. | 21 Aug 2024 | 2,907 | 441,079 (0%) | 0% | 31.8 | 92,559 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 32.32 per share. | 21 Aug 2024 | 120 | 440,959 (0%) | 0% | 32.3 | 3,878 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 29.64 per share. | 17 Jul 2024 | 2,698 | 444,155 (0%) | 0% | 29.6 | 79,969 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 30.55 per share. | 17 Jul 2024 | 169 | 443,986 (0%) | 0% | 30.6 | 5,163 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 28.06 per share. | 09 Jul 2024 | 1,527 | 446,853 (0%) | 0% | 28.1 | 42,848 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 29.65 per share. | 22 May 2024 | 3,247 | 448,380 (0%) | 0% | 29.7 | 96,274 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 28.80 per share. | 17 Apr 2024 | 7,825 | 453,917 (0%) | 0% | 28.8 | 225,360 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 29.94 per share. | 17 Apr 2024 | 2,290 | 451,627 (0%) | 0% | 29.9 | 68,563 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 31.18 per share. | 09 Apr 2024 | 1,053 | 461,742 (0%) | 0% | 31.2 | 32,833 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 68,723 | 68,723 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2024 | 54,978 | 462,795 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Butchko G. Julia | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 36.15 per share. | 22 Feb 2024 | 2,146 | 407,817 (0%) | 0% | 36.2 | 77,578 | Common Stock |
| Immunovant Inc | Butchko Julia G. | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 38.59 per share. | 05 Jan 2024 | 1,297 | 409,963 (0%) | 0% | 38.6 | 50,051 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 20.30 per share. | 24 Aug 2023 | 12,332 | 416,261 (0%) | 0% | 20.3 | 250,340 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 21.00 per share. | 24 Aug 2023 | 1 | 416,260 (0%) | 0% | 21 | 21 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 19.73 per share. | 12 Jul 2023 | 1,470 | 428,593 (0%) | 0% | 19.7 | 29,003 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Development Officer | Sale of securities on an exchange or to another person at price $ 15.27 per share. | 18 Apr 2023 | 1,544 | 430,063 (0%) | 0% | 15.3 | 23,577 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 130,081 | 130,081 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Apr 2023 | 100,188 | 431,607 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 16.79 per share. | 11 Jan 2023 | 60,471 | 331,419 (0%) | 0% | 16.8 | 1,015,308 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 15.16 per share. | 11 Jan 2023 | 19 | 391,890 (0%) | 0% | 15.2 | 288 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 9.18 per share. | 13 Oct 2022 | 928 | 391,909 (0%) | 0% | 9.2 | 8,519 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 4.67 per share. | 28 Sep 2022 | 535 | 392,837 (0%) | 0% | 4.7 | 2,498 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 5.83 per share. | 30 Aug 2022 | 548 | 393,372 (0%) | 0% | 5.8 | 3,195 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 169,648 | 169,648 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 112,816 | 393,920 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 4.27 per share. | 27 Jul 2022 | 510 | 281,104 (0%) | 0% | 4.3 | 2,178 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 4.02 per share. | 29 Jun 2022 | 460 | 281,614 (0%) | 0% | 4.0 | 1,849 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 3.79 per share. | 24 May 2022 | 492 | 282,074 (0%) | 0% | 3.8 | 1,865 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 4.72 per share. | 27 Apr 2022 | 541 | 282,566 (0%) | 0% | 4.7 | 2,554 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 5.90 per share. | 24 Mar 2022 | 6,381 | 283,107 (0%) | 0% | 5.9 | 37,648 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale of securities on an exchange or to another person at price $ 7.25 per share. | 07 Jan 2022 | 55,318 | 289,488 (0%) | 0% | 7.3 | 401,056 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2021 | 319,700 | 319,700 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Sep 2021 | 319,700 | 0 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Sep 2021 | 191,100 | 0 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Sep 2021 | 191,100 | 191,100 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 285,306 | 344,806 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 191,100 | 191,100 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Mar 2021 | 54,500 | 59,500 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Purchase of securities on an exchange or from another person at price $ 38.17 per share. | 11 Sep 2020 | 5,000 | 5,000 (0%) | 0% | 38.2 | 190,850 | Common Stock |
| Immunovant Inc | Julia G. Butchko | Chief Dev. & Tech. Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 319,700 | 319,700 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges